Skip to content
PubMed This is a summary of 18 peer-reviewed journal articles Updated
Endocrinology · Primary Bilateral Macronodular Adrenal Hyperplasia

The Path Forward: Long-Term Health and Genetics

At a Glance

After treatment for PBMAH, lifelong follow-up is important because cortisol excess can return from the remaining adrenal gland or cause lasting heart, bone, and metabolic problems. Bilateral adrenalectomy requires lifelong steroid replacement and emergency planning.

Managing Primary Bilateral Macronodular Adrenal Hyperplasia (PBMAH) or Bilateral Macronodular Adrenal Disease (BMAD) is a marathon, not a sprint. Whether you have had surgery or are being monitored, your health journey moves into a phase of careful, long-term surveillance.

The goal of this phase is twofold: ensuring your cortisol levels remain stable and managing the long-term effects that high cortisol may have had on your heart, bones, and metabolism [1][2].

Life After Unilateral Adrenalectomy

If you had one adrenal gland removed, you likely still have some natural cortisol production. However, because PBMAH is a disease that affects both glands, the remaining gland requires lifelong “watchful waiting” [3][4].

  • Recurrence Monitoring: Research shows that hypercortisolism can return, sometimes years after a successful surgery [5]. In some groups, over 55% of patients saw a return of high cortisol levels within 2.5 years [4]. You will need an individualized plan using appropriate biochemical tests (such as 24-hour urinary free cortisol or ACTH checks) to ensure your levels stay in the healthy range [6][7].
  • Imaging of the Remaining Gland: Routine CT scans are not appropriate for every stable nodule; follow-up imaging depends on the original imaging phenotype, growth, and your symptoms [8].
  • Adrenal Insufficiency: Immediately after surgery, your remaining gland might be “sleepy” and not produce enough cortisol. Up to 40% of patients experience temporary adrenal insufficiency and may need steroid supplements for a few months until the gland “wakes up” [7][3].

Life After Bilateral Adrenalectomy

Removing both glands provides a permanent cure for cortisol excess but creates a new condition: permanent adrenal insufficiency [4].

  • Lifelong Replacement: You must take daily glucocorticoids (like hydrocortisone) and usually mineralocorticoids (like fludrocortisone) to replace what your glands no longer make [9][10].
  • The “Sick Day Rules”: During times of physical stress—such as a high fever, severe injury, or surgery—your body needs more cortisol than your daily pills provide. You must work with your doctor to learn how to “stress dose” (increase your medication) to prevent a life-threatening adrenal crisis [11].
  • Emergency Preparedness: You should always carry a medical alert ID (bracelet or necklace) and have an emergency injectable steroid kit available for situations where you cannot take pills (such as severe vomiting) [11].

Important: Do not stop or reduce your hydrocortisone, fludrocortisone, blood-pressure medication, or diabetes medication without explicit instructions from your treating clinician.

Genetic Information for Relatives

Because a subset of PBMAH cases has an inherited genetic root, your diagnosis can provide vital information for your relatives.

  • ARMC5 Testing: This is a common mutation in inherited PBMAH. It follows an autosomal dominant pattern [12]. If a confirmed pathogenic germline ARMC5 mutation is found, genetic counseling and targeted cascade testing should be offered to your siblings and children [13].
  • Early Detection: Relatives who carry the mutation but don’t have symptoms yet can be monitored closely. This allows doctors to catch cortisol issues early, often before they cause permanent damage to the heart or bones [14][12].

Monitoring Your Long-Term Health

Even after your cortisol is “cured,” your body may still be healing from the years it spent under the influence of high hormones.

Cardiometabolic Health

High cortisol acts like a “multiplier” for cardiovascular risk. After treatment, many patients see their blood pressure and blood sugar improve—sometimes even allowing them to stop their medications [1][7]. However, you must continue to monitor:

  • Blood Pressure: Improvement can be gradual, and some damage to the arteries may persist [7].
  • Diabetes/Glucose: Even if your sugar levels drop, your metabolism may remain sensitive [1].
  • Lipids: Cholesterol levels should be checked regularly to manage overall heart risk [15].

Bone Health

Excess cortisol is “toxic” to bones, often leading to osteoporosis or fractures [16].

  • Beyond the DXA Scan: Standard bone density (DXA) scans may not tell the whole story. Depending on your fracture risk, doctors may also use a Trabecular Bone Score (TBS) alongside DXA. You may be prescribed calcium, vitamin D, or specific bone-strengthening medications (bisphosphonates) as risk-based adjuncts to help your skeleton recover [2].

Emotional Well-being

Long-standing high cortisol can lead to anxiety, depression, or even “brain fog.” Many patients report significant improvements in their mood and psychological clarity within weeks or months of treatment [17][18]. Persistent depression, anxiety, or cognitive symptoms can have several causes and should prompt both medical and mental-health assessment, rather than assuming it is only a hormone adjustment issue.

Common questions in this guide

What follow-up tests are needed after one adrenal gland is removed for PBMAH?
Long-term follow-up is needed because the remaining adrenal gland can become overactive years after surgery. Your clinician may use 24-hour urine cortisol and ACTH tests, and decide whether imaging is needed based on the nodule’s appearance, growth, and your symptoms.
What happens after both adrenal glands are removed?
Both-gland surgery permanently stops the body from making enough cortisol, causing permanent adrenal insufficiency. Daily hydrocortisone and usually fludrocortisone are needed, along with a stress-dose plan, medical alert identification, and an emergency steroid injection kit.
What are sick-day rules after bilateral adrenalectomy?
Fever, serious injury, surgery, and other major physical stress can increase the body’s need for cortisol. Follow the written plan from your clinician for increasing hydrocortisone, use the emergency injection when you cannot keep pills down, and seek urgent care as instructed.
Should my children or siblings have ARMC5 testing?
If a pathogenic inherited ARMC5 mutation is confirmed, genetic counseling and targeted testing may be offered to siblings and children. Relatives who carry the mutation can be monitored for cortisol problems before they cause damage to the heart or bones.
What bone tests might I need after PBMAH?
Years of high cortisol can weaken bones and increase fracture risk. Depending on your risk, your clinician may recommend a DXA scan, vertebral fracture evaluation, or trabecular bone score, along with calcium, vitamin D, or bone-strengthening medicine.
What health checks are important after cortisol levels are controlled?
Follow-up can include blood pressure, blood sugar, cholesterol, bone strength, and emotional or cognitive health. These problems may improve after cortisol is controlled, but recovery can take time and some risks may persist.
Can I stop my blood pressure or diabetes medicines after treatment?
Blood pressure and blood sugar may improve after cortisol excess is treated, but medication changes must be based on home readings, laboratory results, and clinician guidance. Do not reduce or stop these medicines on your own.

Get notified when new evidence is published on Cushing syndrome due to bilateral macronodular adrenocortical disease.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (18)
  1. 1

    Long-term cardiometabolic outcomes of primary bilateral macronodular adrenal hyperplasia.

    Zhou H, Zhang P, Yin Y, et al.

    Journal of endocrinological investigation 2025; (48(6)):1403-1414 doi:10.1007/s40618-025-02561-0.

    PMID: 40252189
  2. 2

    Long-term outcome of unilateral adrenalectomy for primary bilateral macronodular adrenal hyperplasia.

    Zhou H, Yin Y, Zhang P, et al.

    Endocrine 2025; (87(2)):810-821 doi:10.1007/s12020-024-04030-9.

    PMID: 39382825
  3. 3

    A 30-Year, Single-Center Experience of Unilateral Adrenalectomy for Primary Bilateral Macronodular Adrenal Hyperplasia.

    Wang W, Lian P, Deng J, et al.

    Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2022; (28(7)):690-695 doi:10.1016/j.eprac.2022.04.011.

    PMID: 35487460
  4. 4

    Long-Term Outcome of Primary Bilateral Macronodular Adrenocortical Hyperplasia After Unilateral Adrenalectomy.

    Osswald A, Quinkler M, Di Dalmazi G, et al.

    The Journal of clinical endocrinology and metabolism 2019; (104(7)):2985-2993 doi:10.1210/jc.2018-02204.

    PMID: 30844071
  5. 5

    An analysis of different therapeutic options in patients with Cushing's syndrome due to bilateral macronodular adrenal hyperplasia: a single-centre experience.

    Albiger NM, Ceccato F, Zilio M, et al.

    Clinical endocrinology 2015; (82(6)):808-15 doi:10.1111/cen.12763.

    PMID: 25727927
  6. 6

    The effect of unilateral adrenalectomy on patients with primary bilateral macronodular adrenal hyperplasia.

    Yu Z, Gao J, Sun F

    Hormones (Athens, Greece) 2023; (22(2)):235-242 doi:10.1007/s42000-023-00428-8.

    PMID: 36800160
  7. 7

    Unilateral Adrenalectomy as a First-Line Treatment of Cushing's Syndrome in Patients With Primary Bilateral Macronodular Adrenal Hyperplasia.

    Debillon E, Velayoudom-Cephise FL, Salenave S, et al.

    The Journal of clinical endocrinology and metabolism 2015; (100(12)):4417-24 doi:10.1210/jc.2015-2662.

    PMID: 26451908
  8. 8

    Growth Kinetics of Bilateral Macronodular Adrenocortical Disease: Long-Term Imaging Follow-Up in Natural and Surgical Cohorts.

    Xu H, Zhong F, Jiao Q, et al.

    Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2026; (32(6)):868-877 doi:10.1016/j.eprac.2025.12.008.

    PMID: 41419179
  9. 9

    Approach to patients with bilateral adrenal incidentalomas.

    Vassiliadi DA, Partsalaki E, Tsagarakis S

    Current opinion in endocrinology, diabetes, and obesity 2020; (27(3)):125-131 doi:10.1097/MED.0000000000000536.

    PMID: 32209820
  10. 10

    PAI-BEL: a Belgian multicentre survey of primary adrenal insufficiency.

    Driessens N, Prasai M, Alexopoulou O, et al.

    Endocrine connections 2023; (12(6)).

    PMID: 36897769
  11. 11

    Perioperative Risks and Long-Term Outcomes of Bilateral Adrenalectomy: A Multicenter Retrospective Cohort Study Across Cushing's Syndrome and Non-Cushing Etiologies.

    Güngör Semiz G, Yılmaz N, Aydemir M, et al.

    Medicina (Kaunas, Lithuania) 2026; (62(7)) doi:10.3390/medicina62071373.

    PMID: 42512915
  12. 12

    First case report of the ARMC5 (c.2692C>T, p.Arg898Trp) variant in a Chinese family with adrenocorticotropic hormone-independent macronodular adrenal hyperplasia.

    Gai R, Shi C, Guo Z, et al.

    AME case reports 2026; (10()):114 doi:10.21037/acr-2026-0029.

    PMID: 42299397
  13. 13

    Current approach of primary bilateral adrenal hyperplasia.

    Delivanis DA, Vassiliadi DA, Tsagarakis S

    Current opinion in endocrinology, diabetes, and obesity 2022; (29(3)):243-252 doi:10.1097/MED.0000000000000725.

    PMID: 35621176
  14. 14

    ARMC5 mutations in a large French-Canadian family with cortisol-secreting β-adrenergic/vasopressin responsive bilateral macronodular adrenal hyperplasia.

    Bourdeau I, Oble S, Magne F, et al.

    European journal of endocrinology 2016; (174(1)):85-96 doi:10.1530/EJE-15-0642.

    PMID: 26604299
  15. 15

    Effect of surgical versus conservative management on cardiovascular outcomes in patients with bilateral adrenal tumours and cortisol excess: an international, retrospective cohort study.

    Nowak E, Viëtor CL, Feelders RA, et al.

    The lancet. Diabetes & endocrinology 2026; (14(3)):202-215 doi:10.1016/S2213-8587(25)00302-X.

    PMID: 41579871
  16. 16

    Assessment of vertebral microarchitecture in overt and mild Cushing's syndrome using trabecular bone score.

    Vinolas H, Grouthier V, Mehsen-Cetre N, et al.

    Clinical endocrinology 2018; (89(2)):148-154 doi:10.1111/cen.13743.

    PMID: 29781519
  17. 17

    Primary bilateral macronodular adrenal hyperplasia: A rare case report of Cushing syndrome and review of literature.

    Ghanbari Boroujeni MR, Meftah E, Zarimeidani F, et al.

    Medicine 2024; (103(41)):e40050 doi:10.1097/MD.0000000000040050.

    PMID: 39465833
  18. 18

    A Case of Severe Psychosis Due to Cushing's Syndrome Secondary to Primary Bilateral Macronodular Adrenal Hyperplasia.

    Shah K, Mann I, Reddy K, John G

    Cureus 2019; (11(11)):e6162 doi:10.7759/cureus.6162.

    PMID: 31890370

This page is for informational purposes only and does not constitute medical advice. Your endocrinology team should individualize hormone testing, medication changes, genetic evaluation, and emergency steroid planning; never stop or adjust medicines without their instructions.